Serum hepcidin concentrations correlate with ferritin in patients with inflammatory bowel disease

Journal of Crohn's and Colitis

Volumn 8, Issue 11, 2014, Pages 1392-1397

  Mecklenburg, Ingo ^a   Reznik, Diana ^a   Fasler Kan, Elizaveta ^a,b   Drewe, Jürgen ^a   Beglinger, Christoph ^a   Hruz, Petr ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF APPLIED SCIENCES AND ARTS NORTHWESTERN SWITZERLAND   (Switzerland)

Author keywords

Anemia; Crohn's disease; Hepcidin; Inflammatory bowel disease; Ulcerative colitis

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; FERRITIN; HEMOGLOBIN; HEPCIDIN;

ADULT; AGED; ANEMIA; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CROHN DISEASE; CROHN DISEASE ACTIVITY INDEX; DISEASE ACTIVITY SCORE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FERRITIN BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; INFLAMMATORY BOWEL DISEASE; IRON DEFICIENCY; IRON STORAGE; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; REMISSION; RETROSPECTIVE STUDY; ULCERATIVE COLITIS; VERY ELDERLY; ADOLESCENT; ANEMIA, IRON-DEFICIENCY; BLOOD; CASE CONTROL STUDY; COMPLICATION; METABOLISM; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANEMIA, IRON-DEFICIENCY; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; FERRITINS; HEMOGLOBINS; HEPCIDINS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84927796981     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2014.04.008     Document Type: Article

References (22)

1. Podolsky D.K. Inflammatory bowel disease. N Engl J Med 2002, 347:417-429.
2. Abraham C., Medzhitov R. Interactions between the host innate immune system and microbes in inflammatory bowel disease. Gastroenterology 2011, 140:1729-1737.
3. Burisch J., Jess T., Martinato M., Lakatos P.L. The burden of inflammatory bowel disease in Europe. J Crohns Colitis 2013, 7:322-337.
4. Gasche C., Lomer M.C., Cavill I., Weiss G. Iron, anaemia, and inflammatory bowel diseases. Gut 2004, 53:1190-1197.
5. Gomollon F., Gisbert J.P. Anemia and inflammatory bowel diseases. World J Gastroenterol 2009, 15:4659-4665.
6. Voegtlin M., Vavricka S.R., Schoepfer A.M., Straumann A., Voegtlin J., Rogler G., et al. Prevalence of anaemia in inflammatory bowel disease in Switzerland: a cross-sectional study in patients from private practices and university hospitals. J Crohns Colitis 2010, 4:642-648.
7. Weiss G., Gasche C. Pathogenesis and treatment of anemia in inflammatory bowel disease. Haematologica 2010, 95:175-178.
8. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 2003, 102:783-788.
9. Nemeth E., Tuttle M.S., Powelson J., Vaughn M.B., Donovan A., Ward D.M., et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004, 306:2090-2093.
10. Arnold J., Sangwaiya A., Bhatkal B., Geoghegan F., Busbridge M. Hepcidin and inflammatory bowel disease: dual role in host defence and iron homoeostasis. Eur J Gastroenterol Hepatol 2009, 21:425-429.
11. Basseri R.J., Nemeth E., Vassilaki M.E., Basseri B., Enayati P., Shaye O., et al. Hepcidin is a key mediator of anemia of inflammation in Crohn's disease. J Crohns Colitis 2013, 7:e286-e291.
12. Nagy J., Lakner L., Poor V.S., Pandur E., Mozsik G., Miseta A., et al. Serum prohepcidin levels in chronic inflammatory bowel diseases. J Crohns Colitis 2010, 4:649-653.
13. Oustamanolakis P., Koutroubakis I.E., Messaritakis I., Malliaraki N., Sfiridaki A., Kouroumalis E.A. Serum hepcidin and prohepcidin concentrations in inflammatory bowel disease. Eur J Gastroenterol Hepatol 2011, 23:262-268.
14. Wang L., Trebicka E., Fu Y., Ellenbogen S., Hong C.C., Babitt J.L., et al. The bone morphogenetic protein-hepcidin axis as a therapeutic target in inflammatory bowel disease. Inflamm Bowel Dis 2011, 18:112-119.
15. Wrighting D.M., Andrews N.C. Interleukin-6 induces hepcidin expression through STAT3. Blood 2006, 108:3204-3209.
16. Pittet V., Juillerat P., Mottet C., Felley C., Ballabeni P., Burnand B., et al. Cohort profile: the Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS). Int J Epidemiol 2009, 38:922-931.
17. Lennard-Jones J.E. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 1989, 170:2-6. [discussion 16-9].
18. Kemna E., Pickkers P., Nemeth E., van der Hoeven H., Swinkels D. Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS. Blood 2005, 106:1864-1866.
19. Nemeth E., Rivera S., Gabayan V., Keller C., Taudorf S., Pedersen B.K., et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 2004, 113:1271-1276.
20. Nicolas G., Chauvet C., Viatte L., Danan J.L., Bigard X., Devaux I., et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest 2002, 110:1037-1044.
21. Semrin G., Fishman D.S., Bousvaros A., Zholudev A., Saunders A.C., Correia C.E., et al. Impaired intestinal iron absorption in Crohn's disease correlates with disease activity and markers of inflammation. Inflamm Bowel Dis 2006, 12:1101-1106.
22. Theurl I., Schroll A., Sonnweber T., Nairz M., Theurl M., Willenbacher W., et al. Pharmacologic inhibition of hepcidin expression reverses anemia of chronic inflammation in rats. Blood 2011, 118:4977-4984.